Article

Mining transcriptomics and clinical data reveals ACE2 expression modulators and identifies cardiomyopathy as a risk factor for mortality in COVID-19 patients

2020-10-23

Abstract excerpt

Angiotensin-converting enzyme 2 ( ACE2 ) is the cell-entry receptor for SARS-CoV-2. It plays critical roles in both the transmission and the pathogenesis of the coronavirus disease 2019 (COVID-19). Comprehensive profiling of ACE2 expression patterns will help researchers to reveal risk factors of severe COVID-19 illness. While the expression of ACE2 in healthy human tissues has been well characterized, it is not k...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9f4096c4-80de-5950-86aa-2ca054f0886e
DOI: 10.1101/2020.10.20.20216150

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Mining transcriptomics and clinical data reveals ACE2 expression modulators and identifies cardiomyopathy as a risk factor for mortality in COVID-19 patientsDOI 10.1101/2020.10.20.20216150Read

Systematic identification of ACE2 expression modulators reveals cardiomyopathy as a risk factor for mortality in COVID-19 patientsSemantic proximity Read

ACE2 Interaction Networks in COVID-19: A Physiological Framework for Prediction of Outcome in Patients with Cardiovascular Risk FactorsSemantic proximity Read

ACE2 interaction networks in COVID-19: a physiological framework for prediction of outcome in patients with cardiovascular risk factorsSemantic proximity Read

Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation.Semantic proximity Read

Systematic Cell Line-Based Identification of Drugs Modifying <i>ACE2</i> ExpressionSemantic proximity Read

ACE2 Expression is Increased in the Lungs of Patients with Comorbidities Associated with Severe COVID-19Semantic proximity Read

Integrative clinical, genomics and metabolomics data analysis for mainstream precision medicine to investigate COVID-19Semantic proximity Read

ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19Semantic proximity Read

Integrative transcriptome analyses empower the anti-COVID-19 drug arsenalSemantic proximity Read

Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditionsSemantic proximity Read

ACE2 Netlas: In-silico functional characterization and drug-gene interactions of <i>ACE2</i> gene network to understand its potential involvement in COVID-19 susceptibilitySemantic proximity Read

ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy.Semantic proximity Read